SMTL ID : 2vz2.1

Human MAO B in complex with mofegiline

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Covalent)

FAD.1: 37 residues within 4Å: Chain A: V.10, G.11, G.12, G.13, I.14, S.15, L.33, E.34, A.35, R.36, G.40, G.41, R.42, T.43, L.56, G.57, G.58, S.59, Y.60, R.233, P.234, V.235, A.263, I.264, P.265, L.268, W.388, Y.393, C.397, Y.398, G.425, T.426, G.434, Y.435, M.436, A.439 Ligands: MFG.2 31 PLIP interactions: 31 interactions with chain A Hydrophobic interactions: A:W.388, A:Y.398, A:Y.398 Hydrogen bonds: A:G.12, A:G.13, A:S.15, A:A.35, A:R.36, A:R.42, A:G.58, A:S.59, A:Y.60, A:Y.60, A:V.235, A:V.235, A:T.426, A:T.426, A:G.434, A:M.436 Water bridges: A:I.14, A:I.14, A:G.16, A:E.34, A:E.34, A:R.42, A:R.42, A:Q.65, A:E.437 Salt bridges: A:R.42, A:R.42 pi-Stacking: A:Y.393 FAD.4: 37 residues within 4Å: Chain B: V.10, G.11, G.12, G.13, I.14, S.15, L.33, E.34, A.35, R.36, G.40, G.41, R.42, T.43, L.56, G.57, G.58, S.59, Y.60, R.233, P.234, V.235, A.263, I.264, P.265, L.268, W.388, Y.393, C.397, Y.398, G.425, T.426, G.434, Y.435, M.436, A.439 Ligands: MFG.5 31 PLIP interactions: 31 interactions with chain B Hydrophobic interactions: B:W.388, B:Y.398, B:Y.398 Hydrogen bonds: B:G.12, B:G.13, B:S.15, B:A.35, B:R.36, B:R.42, B:G.58, B:S.59, B:Y.60, B:Y.60, B:V.235, B:V.235, B:T.426, B:G.434, B:M.436 Water bridges: B:I.14, B:I.14, B:G.16, B:E.34, B:E.34, B:R.42, B:R.42, B:Q.65, B:E.437 Salt bridges: B:R.42, B:R.42 pi-Stacking: B:Y.393, B:Y.435

2 x MFG: (1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE

MFG.2: 9 residues within 4Å: Chain A: L.171, I.198, I.199, Q.206, Y.326, Y.398, G.434, Y.435 Ligands: FAD.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.171, A:L.171, A:Q.206, A:Y.326, A:Y.398, A:Y.398 Hydrogen bonds: A:G.434 MFG.5: 9 residues within 4Å: Chain B: L.171, I.198, I.199, Q.206, Y.326, Y.398, G.434, Y.435 Ligands: FAD.4 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:L.171, B:L.171, B:Q.206, B:Y.326, B:Y.398, B:Y.398 Hydrogen bonds: B:G.434

2 x C15: N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE(Non-covalent)

C15.3: 4 residues within 4Å: Chain A: D.153, K.154, C.156, W.157 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:W.157 pi-Cation interactions: A:W.157, A:W.157 C15.6: 3 residues within 4Å: Chain B: D.153, K.154, W.157 2 PLIP interactions: 2 interactions with chain B pi-Cation interactions: B:W.157, B:W.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Milczek, E.M. et al., Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B. J. Med. Chem. (2008)

Release Date

2008-12-16

Peptides

AMINE OXIDASE [FLAVIN-CONTAINING] B: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

AMINE OXIDASE [FLAVIN-CONTAINING] B

Related Entries With Identical Sequence